HIV/AIDS

Vaccines

According to the latest United Nations estimates, worldwide more than 40 million people are infected with HIV, and the prevalence levels for this virus will continue to rise globally. Historically, vaccines have proven to be the most effective weapon in our fight against infectious diseases such as smallpox, polio, measles, and yellow fever. HIV vaccines are our best hope to end the HIV pandemic.

• Introduction and Goals
• Research Activities
• Resources for Researchers
• Funding
• Meetings
• Reports and Articles
• Advisory and Working Groups
• Clinical Trials

Special Announcements

Check Out Potential New Funding Opportunities on HIV Vaccine Research from NIAID

Connecting HIV Vaccinology and B-cell Biology

Considerations for HIV Vaccine Clinical Trials in Adolescents

Latest News in NIAID HIV Vaccine Research

NIAID HIV Vaccine Research Education Initiative (NHVREI)

Latest News in NIAID HIV Vaccine Research

From Our Partners

• Center for HIV/AIDS Vaccine Immunology (CHAVI): Forging New Way Ahead
• HIV Vaccine Trials Network (HVTN): Reshaped scientific agenda involves understanding the clinical and immunological aspects of the Step trial

HIV Vaccine Research

• Keystone Symposia 2008 - Recalibration of the HIV Vaccine Field
• AIDS Vaccine 2008 - New Discoveries Energize the HIV Vaccine Field

back to top